For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...

In a new study published in Liver Research, a team of researchers in China discovered that nicotinic acid-a common form of ...

Liver resection should be the primary therapeutic option for patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for transplant, a retrospective cohort study suggested.

In a new study published in Liver Research, a team of researchers in China discovered that nicotinic acid-a common form of ...

Recurrence beyond Milan criteria predicts worse outcomes after hepatocellular carcinoma resection. Limited recurrence remains manageable.

Previous reports have also described the safety of resecting segments 7 and 8. However, they drew conclusions on smaller cohorts than our present study, and some included segments 1, 4a, 7, and 8, ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

It’s well known that the liver is the only organ in the human body that can regenerate. Sometimes, the renewal process fails, and a transplant is required. Researchers have now discovered why this ...

The study reveals that nicotinic acid (vitamin B3) significantly protects the liver during ischemia-reperfusion injury by ...